Michael Flynn qualified as a physician from Kings College Hospital, London in 1965. He has spent over 35 years in the pharmaceutical industry serving on the board of directors of a number of private and public companies in the healthcare sector and most recently was Chief Executive Officer of Sinclair Pharma plc until December 2009. He is presently a director of a number of small healthcare companies. Dr Flynn was elected a Fellow by Distinction of the Faculty of Pharmaceutical Medicine of the Royal College of physicians in 2001.
William Marshall is a retired metabolic physician and clinical biochemist, who worked at King ‘s College Hospital, London, and The London Clinic. His major clinical interest was in the management of risk factors for cardiovascular disease, and he was active in both undergraduate and postgraduate medical education. He remains active as a medical writer and editor, and is currently Director of Finance for the Association of Clinical Biochemistry and Laboratory Medicine, having previously been Hon. Treasurer of the Royal College of Pathologists and the Society of Biology.
John Jackson is a semi-retired human resource professional who runs his own HR consultancy in West London. He is an ex-trustee for the St Andrew’s Church Centre, a Church-based community centre in Ealing, which he helped found and chair for a number of years. John is a Chartered Fellow of the Chartered Institute for Personnel Development (CIPD)) and provides free mentoring services for members of the CIPD’s West London branch. John also uses his HR expertise to provide pro-bono training for a select number of small charities.
Andrew Shindler is a solicitor and partner in the Commerce & Technology at the London office of Lock Lorde LLP, Andrew has some twenty years’ experience specialising in contracts relating to the exploitation of intellectual property rights and other commercial agreements. He is particularly involved in advising, drafting and negotiating research, development and licence agreements in the pharmaceutical industry. Andrew’s pharmaceutical practice focuses mainly on acting for small and medium size pharmaceutical, biopharmaceutical and biotech companies in their research, development, licensing and other collaboration agreements with big pharma, in the course of which he has drafted and negotiated deals with many of the world’s largest pharmaceutical companies.
Donald Singer is President of the Fellowship of Postgraduate Medicine and Secretary of the European Association for Clinical Pharmacology and Therapeutics. He has worked for the University of Yale and the St George’s University Hospital London and has worked on medicine and patients safety as a pharmacologist within the 7 year Human Resources for Health programme in Rwanda, which aims to create a high quality national health system for the country. He was also foundation holder of the Chair of Clinical Pharmacology and Therapeutics at the Graduate Medical School at Warwick University where he founded the Clinical Sciences Division in 2003. He is an active clinician with clinical interests in prevention and treatment of cardiovascular disease and safe use of medicines. His main research interests are in causes of vascular disease, better management of blood pressure and improved patient safety through new systems aimed at improving safety in prescribing. In 2009, with international poet Michael Hulse, he launched the annual International Hippocrates Prize for Poetry and Medicine, which has attracted interest from over 60 countries. He was formerly Trustee of Richmond Orchestra and Ealing Junior Music School.